{{ variable.name }} : {{ variable.values[selectedVariantsIndex[variable_index]].name }}
Quantity:
CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog designed to stimulate the pituitary gland to produce and release human growth hormone (HGH).
• Mechanism: It mimics natural GHRH, signaling the pituitary gland to secrete growth hormone, which in turn raises levels of insulin-like growth factor 1 (IGF-1).
• DAC vs. No-DAC:
• With DAC (Drug Affinity Complex): Binds to albumin in the bloodstream, giving it a long half-life (about 6 to 8 days) and resulting in continuous, elevated GH levels.
• Without DAC (Mod GRF 1-29): Has a much shorter half-life, creating short, natural-like pulses of growth hormone rather than a constant stream.
Common Uses & Reported Claims
Users and alternative health clinics often market CJC-1295 (frequently paired with Ipamorelin) for purported benefits, though large-scale human clinical safety data are lacking:
• Increasing lean muscle mass and supporting fat loss
• Enhancing exercise recovery and tissue/joint repair
• Improving sleep quality
• Anti-aging and general vitality
• Side Effects & Uncertainty: Long-term human safety trials are limited. Side effects can include injection-site reactions, water retention, flushing, or altered insulin sensitivity/glucose levels.